203 related articles for article (PubMed ID: 31801542)
1. Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study.
Lourenço J; Obolski U; Swarthout TD; Gori A; Bar-Zeev N; Everett D; Kamng'ona AW; Mwalukomo TS; Mataya AA; Mwansambo C; Banda M; Gupta S; French N; Heyderman RS
BMC Med; 2019 Dec; 17(1):219. PubMed ID: 31801542
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
Heinsbroek E; Tafatatha T; Phiri A; Swarthout TD; Alaerts M; Crampin AC; Chisambo C; Mwiba O; Read JM; French N
Vaccine; 2018 Nov; 36(48):7369-7376. PubMed ID: 30352744
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine.
von Mollendorf C; Dunne EM; La Vincente S; Ulziibayar M; Suuri B; Luvsantseren D; Narangerel D; Ortika BD; Pell CL; Nation ML; Alamrousi A; Hinds J; Demberelsuren S; Nguyen C; Mungun T; Mulholland EK; Satzke C
Vaccine; 2019 Jul; 37(30):4068-4075. PubMed ID: 31174939
[TBL] [Abstract][Full Text] [Related]
4. A pragmatic health centre-based evaluation comparing the effectiveness of a PCV13 schedule change from 3+0 to 2+1 in a high pneumococcal carriage and disease burden setting in Malawi: a study protocol.
Swarthout TD; Ibarz-Pavon A; Kawalazira G; Sinjani G; Chirombo J; Gori A; Chalusa P; Bonomali F; Nyirenda R; Bulla E; Brown C; Msefula J; Banda M; Kachala J; Mwansambo C; Henrion MY; Gordon SB; French N; Heyderman RS
BMJ Open; 2021 Jun; 11(6):e050312. PubMed ID: 34140345
[TBL] [Abstract][Full Text] [Related]
5. High multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children.
Kamng'ona AW; Hinds J; Bar-Zeev N; Gould KA; Chaguza C; Msefula C; Cornick JE; Kulohoma BW; Gray K; Bentley SD; French N; Heyderman RS; Everett DB
BMC Infect Dis; 2015 Jun; 15():234. PubMed ID: 26088623
[TBL] [Abstract][Full Text] [Related]
6. Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi.
Kirolos A; Swarthout TD; Mataya AA; Bonomali F; Brown C; Msefula J; Bar-Zeev N; Iroh Tam PY; Alaerts M; Bilima S; Heyderman RS; French N
BMC Infect Dis; 2023 Jan; 23(1):56. PubMed ID: 36703117
[TBL] [Abstract][Full Text] [Related]
7. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi.
Swarthout TD; Fronterre C; Lourenço J; Obolski U; Gori A; Bar-Zeev N; Everett D; Kamng'ona AW; Mwalukomo TS; Mataya AA; Mwansambo C; Banda M; Gupta S; Diggle P; French N; Heyderman RS
Nat Commun; 2020 May; 11(1):2222. PubMed ID: 32376860
[TBL] [Abstract][Full Text] [Related]
8. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
[TBL] [Abstract][Full Text] [Related]
9. Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study.
Dula D; Morton B; Chikaonda T; Chirwa AE; Nsomba E; Nkhoma V; Ngoliwa C; Sichone S; Galafa B; Tembo G; Chaponda M; Toto N; Kamng'ona R; Makhaza L; Muyaya A; Thole F; Kudowa E; Howard A; Kenny-Nyazika T; Ndaferankhande J; Mkandawire C; Chiwala G; Chimgoneko L; Banda NPK; Rylance J; Ferreira D; Jambo K; Henrion MYR; Gordon SB;
Lancet Microbe; 2023 Sep; 4(9):e683-e691. PubMed ID: 37659418
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
[TBL] [Abstract][Full Text] [Related]
11. Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study.
Koenraads M; Swarthout TD; Bar-Zeev N; Brown C; Msefula J; Denis B; Dube Q; Gordon SB; Heyderman RS; Gladstone MJ; French N
Pediatr Infect Dis J; 2022 Sep; 41(9):764-768. PubMed ID: 35703302
[TBL] [Abstract][Full Text] [Related]
12. Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys.
Mackenzie GA; Hossain I; Salaudeen R; Badji H; Manjang A; Usuf E; Bottomley C; Greenwood B; Hill PC
Vaccine; 2024 Apr; 42(10):2680-2686. PubMed ID: 38490820
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
[TBL] [Abstract][Full Text] [Related]
14. Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13.
Løvlie A; Vestrheim DF; Aaberge IS; Steens A
BMC Infect Dis; 2020 Jan; 20(1):29. PubMed ID: 31924177
[TBL] [Abstract][Full Text] [Related]
15. Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study.
Flasche S; Lipsitch M; Ojal J; Pinsent A
BMC Med; 2020 Jun; 18(1):129. PubMed ID: 32517683
[TBL] [Abstract][Full Text] [Related]
16. Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People's Democratic Republic.
Chan J; Lai JYR; Nguyen CD; Vilivong K; Dunne EM; Dubot-Pérès A; Fox K; Hinds J; Moore KA; Nation ML; Pell CL; Xeuatvongsa A; Vongsouvath M; Newton PN; Mulholland K; Satzke C; Dance DAB; Russell FM;
BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34108146
[TBL] [Abstract][Full Text] [Related]
17. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
Milucky J; Carvalho MG; Rouphael N; Bennett NM; Talbot HK; Harrison LH; Farley MM; Walston J; Pimenta F; Lessa FC;
Vaccine; 2019 Feb; 37(8):1094-1100. PubMed ID: 30685247
[TBL] [Abstract][Full Text] [Related]
19. Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage.
Valente C; Hinds J; Gould KA; Pinto FR; de Lencastre H; Sá-Leão R
Vaccine; 2016 Jul; 34(34):4072-8. PubMed ID: 27325351
[TBL] [Abstract][Full Text] [Related]
20. Impact of thirteen-valent pneumococcal conjugate vaccine on nasopharyngeal carriage in healthy children under 24 months in Okinawa, Japan.
Chang B; Akeda H; Nakamura Y; Hamabata H; Ameku K; Toma T; Miyagi M; Ohnishi M
J Infect Chemother; 2020 May; 26(5):465-470. PubMed ID: 31926843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
